We are live on ! Find out more
CEMP

Cempra, Inc.
CEMP

Delisted

CEMP was delisted on the 3rd of November, 2017.

130 hedge funds and large institutions have $81.7M invested in Cempra, Inc. in 2016 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 33 increasing their positions, 36 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less call options, than puts

Call options by funds: $3.14M | Put options by funds: $3.26M

8% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 36

13% less funds holding

Funds holding: 149130 (-19)

27% less first-time investments, than exits

New positions opened: 46 | Existing positions closed: 63

92% less capital invested

Capital invested by funds: $976M → $81.7M (-$894M)

100% less funds holding in top 10

Funds holding in top 10: 40 (-4)

Holders
130
Holders Change
-19
Holders Change %
-12.75%
% of All Funds
3.25%
Holding in Top 10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
New
46
Increased
33
Reduced
36
Closed
63
Calls
$3.14M
Puts
$3.26M
Net Calls
-$119K
Net Calls Change
+$7.61M
Name Holding Trade Value Shares
Change
Change in
Stake
Swiss National Bank
51
Swiss National Bank
Switzerland
$171K
DekaBank Deutsche Girozentrale
52
DekaBank Deutsche Girozentrale
Germany
$170K +$24.3K +2,000 +8%
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$152K +$91K +7,501 +16%
PIM
54
Platinum Investment Management
Australia
$141K +$217K +17,900 +55%
Group One Trading
55
Group One Trading
Illinois
$139K +$604K +49,805 New
SG Americas Securities
56
SG Americas Securities
New York
$132K +$388K +32,016 +213%
New York State Common Retirement Fund
57
New York State Common Retirement Fund
New York
$131K -$1.19M -97,880 -68%
FSA
58
Franklin Street Advisors
North Carolina
$127K -$25.5K -2,100 -4%
WIM
59
Wittenberg Investment Management
Massachusetts
$123K +$534K +44,000 New
SM
60
Sabby Management
Florida
$121K +$523K +43,121 New
ProShare Advisors
61
ProShare Advisors
Maryland
$117K +$47.5K +3,918 +10%
Citadel Advisors
62
Citadel Advisors
Florida
$117K +$506K +41,744 New
Dimensional Fund Advisors
63
Dimensional Fund Advisors
Texas
$111K +$481K +39,631 New
GI
64
GAMCO Investors
Connecticut
$108K -$179K -14,800 -28%
Squarepoint
65
Squarepoint
New York
$106K +$461K +37,972 New
VEA
66
Virtus ETF Advisers
New York
$101K +$274K +22,609 +170%
NFA
67
Nationwide Fund Advisors
Ohio
$94K +$51.3K +4,226 +14%
Manulife (Manufacturers Life Insurance)
68
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$90K +$37.1K +3,057 +11%
LCS
69
Levin Capital Strategies
New York
$88K -$11.6M -953,566 -97%
ARTA
70
A.R.T. Advisors
New York
$88K +$384K +31,700 New
Stifel Financial
71
Stifel Financial
Missouri
$87K -$727K -59,953 -64%
FRM
72
Fox Run Management
Connecticut
$85K +$369K +30,400 New
PGCM
73
Prescott Group Capital Management
Oklahoma
$77K +$335K +27,630 New
PAM
74
Paradigm Asset Management
New York
$75.3K -$9.7K -800 -3%
HLA
75
Hamilton Lane Advisors
Pennsylvania
$75K +$323K +26,653 New

CEMP Hedge Fund Activity: Q4 2016 in Review

130 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cempra, Inc. (CEMP) for Q4 2016, worth a combined $81.7M — down 92% from $976M a quarter earlier.

Sellers outnumbered buyers: 63 funds closed out of CEMP and 46 opened new positions — a net loss of 17 holders — while 36 trimmed existing stakes and 33 added.

The largest buyer was Deutsche Bank, adding an estimated $13M. The largest seller was BB Biotech, exiting entirely with an estimated $49.4M sold.

  • 130 institutional investors held Cempra, Inc. (CEMP) as of Q4 2016, down from 149 in Q3 2016.
  • Funds reported $81.7M of Cempra, Inc. stock for Q4 2016, down 92% quarter-over-quarter.
  • 46 funds opened new Cempra, Inc. positions in Q4 2016 and 63 closed out, a net change of -17 holders.
  • The largest Cempra, Inc. buyer in Q4 2016 was Deutsche Bank, an estimated $13M added.
  • The largest Cempra, Inc. seller in Q4 2016 was BB Biotech, an estimated $49.4M sold.

Based on aggregated 13F filings for Q4 2016.